Multi-modal virtual reminiscence therapy with an AI avatar for older adults with Alzheimer's and related dementias
Official title: Multi-modal Large Language Model-Empowered Talk Therapy for Older Adults With ADRD
Run by Indiana University · NCT07499570 · Data updated 2026-11-12
This study will test whether a smart virtual reminiscence program with an interactive avatar can reduce behavioral and psychological symptoms in older adults with mild Alzheimer's or related dementias.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 65 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Indiana University Academic / other |
| Locations | 1 site (Indianapolis, Indiana) |
| Status | Recruiting |
| Started | September 3, 2025 |
| Main results expected | March 1, 2027 |
| Study ends | March 1, 2027 |
| Registry record updated | May 6, 2026 |
| Trial ID | NCT07499570 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are community-dwelling adults aged 65 or older with mild cognitive impairment or mild Alzheimer's-related dementia, elevated BPSD (HABC score >14), reliable internet access, the ability to consent, and a willing care partner.
✕Probably not a fit
Patients in assisted living or nursing homes, those with moderate to severe dementia, or with life expectancy under six months are unlikely to benefit or be eligible for this intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Patient–caregiver dyads are randomized to receive Smart Virtual Reminiscence (SVR) therapy delivered by a multi-modal avatar or an attention control of listening to music. SVR is a computer-accessible program that uses large language model–driven speech understanding, avatar nonverbal cues, and automatically assembled personal reminiscence materials (photos, music, videos) so a human facilitator is not required. Sessions can be completed at the study site or at home via a reliable internet connection with caregiver support as needed. The study measures changes in behavioral and psychological symptoms of dementia using caregiver- and self-report instruments.
Why it matters
Potential benefit: If successful, SVR could provide a scalable, at-home non-drug therapy that lessens agitation, anxiety, and other behavioral symptoms and improves patient well-being.
How similar studies have gone: Reminiscence therapy and other nonpharmacological approaches have shown benefits for mood and behavioral symptoms, but fully automated LLM-driven avatar delivery is novel and has limited prior testing.
Who can join: the full rules
Show full inclusion / exclusion criteria
For the patient: Inclusion criteria: * age ≥ 65 years * diagnosis of MCI (mild cognitive impairment) or mild ADRD * access to a reliable internet connection * community-dwelling * elevated behavioral and psychological symptoms of dementia (BPSD), indicated by a HABC (Healthy Aging Brain Care) monitor score above 14 on caregiver report or self report (indicating elevated levels of BPSD) * presence of one or more specific BPSD behaviors (e.g., agitation, anxiety, depression, apathy, or sleep disturbances) * ability to consent for themselves. Exclusion criteria: * lives in an assisted living facility or nursing home * has moderate to severe ADRD as measured by the Quick Dementia Rating System * has a life expectancy of less than 6 months. For the care partner: Inclusion criteria: * ≥ 21 years old * self-identified care partner (e.g., is knowledgeable about the patient's daytime and nighttime behaviors) of a community-dwelling patient diagnosed with MCI or mild ADRD who will also participate in the study Exclusion criteria: * has MCI or dementia * has a severe mental illness or substance abuse * has a life expectancy of less than 6 months.
Where it's running
-
Sidney & Lois Eskenazi Hospital
Indianapolis, Indiana, United States Recruiting
Study contacts
- Principal investigator: Malaz Boustani, MD, MPH — Indiana University
- Study coordinator: Katrina Coppedge, BA
- Email: kcoppedg@iu.edu
- Phone: 317-278-1602
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
One-day exercise test to see how brain and body react in epilepsy, cognitive disorders, Parkinson's, dementia, and related conditions
A one-day study tests how an acute bout of exercise changes brain function and bodily signals in people with certain neurological conditions compared with healthy individuals.
-
Gut and Oral Microbiome and Cognitive Health in Aging
This study tests whether differences in gut and mouth bacteria are linked to cognitive health in adults across ages and cognitive status.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
AI-supported sleep program for people with mild cognitive impairment or dementia
A small randomized trial tests an AI-assisted behavioral sleep program to help people with mild cognitive impairment or mild dementia who have sleep problems.
-
Blood tests using plasma biomarkers to diagnose and track Alzheimer’s disease
A large, year-long study in Milan is testing whether blood markers can help diagnose Alzheimer’s and predict how it will progress in people with memory concerns.
-
Music for Pain and Dementia: Group Drumming for people with early dementia and their caregivers
This study tests whether group drumming can reduce pain and change brain activity in people with mild dementia or mild cognitive impairment and in their caregivers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.